NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage…
Company to highlight preclinical study of ARV-393, an investigational PROTAC BCL6 degrader, in combination with standard of care therapiesNEW HAVEN,…
ROCKVILLE, Md. and SUZHOU, China, April 21, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical…
The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90).The Company to…
SpaceX's 32nd resupply mission for NASA includes ISS National Lab-sponsored biomedical research, physical sciences projects, technology demonstrations, and NSF-funded science…
RESTON, Va., April 18, 2025 /PRNewswire/ -- Leidos (NYSE: LDOS) is committing $10 million to accelerate the use of artificial…
CrazyBulk CrazyBulk Madison Avenue, New York City, April 18, 2025 (GLOBE NEWSWIRE) -- Looking to take your bodybuilding game to…
NEW CASTLE, Del., April 17, 2025 /PRNewswire/ -- IgniteData, the leader in eSource to sponsor interoperability for clinical research, is…
Researchers to launch a new project leveraging the ISS National Lab to Improve Nanomaterial Production for Future Osteoarthritis and Cancer…
MANCHESTER, England, April 17, 2025 /PRNewswire/ -- Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for…